All Companies
LLY
Eli Lilly & Co.Pharmaceutical Preparations
$1,152.93updated Sep 19, 2026
Congressional trading profile for Eli Lilly & Co. (LLY), covering 53 disclosed transactions by 22 lawmakers.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Total Trades
53
Politicians Trading
22
Last Traded
Jul 10, 2026
Price history